Investor List:

Top Therapeutics Seed Investors in San Francisco Bay Area (68)

Know someone who's actively diligencing and investing? Add them to this list.

About this list

We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.

Photo of Alex Davidov, General Partner at Abstract Ventures

Abstract Ventures·General Partner

Sweet spot: $500K

Range: $250K - $750K

Investors in San Francisco (CA)

Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Cybersecurity (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Cybersecurity (Seed), Investors in Insurance (Pre-seed), Investors in Cybersecurity (Seed), Investors in Insurance (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Insurance (Seed), Investors in Web3/Blockchain (Pre-seed), Investors in BioTech (Pre-seed), Investors in Insurance (Seed), Investors in Web3/Crypto (Pre-seed), Investors in BioTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in FinTech (Pre-seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in SaaS (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in FinTech (Pre-seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in SaaS (Pre-seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Alex

Photo of Josh Wolfe, Managing Partner at Lux Capital Management

Lux Capital Management·Managing Partner

Sweet spot: $50.0M

Range: $1M - $100.0M

Investors in New York (NY), Investors in Menlo Park (CA)

Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Enterprise Applications (Series A), Investors in Health IT (Series A), Investors in Enterprise Applications (Seed), Investors in Health IT (Seed), Investors in Enterprise Applications (Series A), Investors in Digital Health (Series A), Investors in Enterprise Applications (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Josh

Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures

Digitalis Ventures·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)

Investors in Diagnostics (Series A), Investors in Therapeutics (Seed), Investors in Diagnostics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Digital Health (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Series B), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Series B), Investors in Health IT (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Manufacturing (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Geoffrey

Photo of Dave Morin, Managing Partner at Offline Ventures

Offline Ventures·Managing Partner

Sweet spot: $1M

Range: $500K - $5.0M

Investors in SF Bay Area (CA), Investors in California

Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Space (Seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in EnergyTech (Seed), Investors in Web3/Crypto (Pre-seed), Investors in Robotics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Seed), Investors in Social Networks (Pre-seed), Investors in BioTech (Pre-seed), Investors in Robotics (Seed), Investors in EnergyTech (Seed), Investors in Social Networks (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Robotics (Seed), Investors in Web3/Crypto (Seed), Investors in AI (Pre-seed), Investors in BioTech (Seed), Investors in Social Networks (Seed), Investors in Consumer Internet (Pre-seed), Investors in Social Networks (Seed), Investors in AI (Pre-seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Internet (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Dave

Photo of David Singer, Managing Partner at Maverick Capital

Maverick Capital·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in San Francisco (CA)

Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to David

Photo of Johnny Hu, Principal at Menlo Ventures

Menlo Ventures·Principal

Sweet spot: $12.0M

Range: $8.0M - $15.0M

Investors in SF Bay Area (CA), Investors in San Francisco (CA)

Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Johnny

Photo of Samuel Bjork, Partner at Digitalis Ventures

Digitalis Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA)

Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Samuel

Photo of Robert Nelsen, Managing Director at ARCH Venture Partners

ARCH Venture Partners·Managing Director

Sweet spot: $75.0M

Range: $50K - $150.0M

Investors in SF Bay Area (CA), Investors in Chicago (IL), Investors in Seattle (WA), Investors in Global

Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Series A), Investors in BioTech (Seed), Investors in Wellness & Fitness (Series A), Investors in BioTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in AI (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Seattle / Portland (Other Lists), Investors in SaaS (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Midwest (Other Lists), Investors in AI (Series A), Investors in SaaS (Series A), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Robert